
Episodes

Tuesday Jun 21, 2022
Imiquimod for BCC with Dr Yevgeny Filanovsky
Tuesday Jun 21, 2022
Tuesday Jun 21, 2022
In this latest podcast, Prof David Wilkinson (Chief Medical Officer of National Skin Cancer Centres) speaks with Dr Yevgeny (Gene) Filanovsky (a Family Physician with Cutaneous Surgery and Skin Cancer Focus at Skin Care West, Canada) about how he uses imiquimod in his practice for the treatment of BCC.
Dr Filanovsky describes his work in cutaneous surgery at Skin Care West in Canada which utilises a team-based approach combining dermatologists and family physicians. This model is developing popularity in Australia too, due to a shortage of dermatologists and a high prevalence of skin cancer.
Dr Filanovsky goes on to give a detailed explanation of how he uses the topical field treatment imiquimod in his practice, especially for the treatment of basal cell carcinoma (BCC).
He also speaks about the surgical options for treating BCCs, including excision guidelines and when the use of topical therapies is appropriate instead of surgical intervention.
Dr Filanovsky discusses the sites, lesion types and patient groups for which he recommends imiquimod.
He has made the following available for download:
You can also visit his website here.

Tuesday Jun 07, 2022
The future of digital imaging for skin cancer detection with Prof Peter Soyer
Tuesday Jun 07, 2022
Tuesday Jun 07, 2022
In this latest podcast, Professor Peter Soyer gives a sneak peek into his presentation at the upcoming Skin & Skin Cancer Conference and Masterclasses, where he will talk about his latest groundbreaking research projects and the future of digital imaging in skin cancer detection.
In the podcast, Prof Soyer talks with Professor David Wilkinson about the latest research projects underway in melanoma, including The University of Queensland Australian Centre of Excellence in Melanoma Imaging & Diagnosis IMAGE trial, the Melanoma Cohort study, and more.
He speaks about how digital imaging will become a mainstay of skin cancer detection in years to come and how it might fit into the everyday workflow of primary care skin cancer doctors.
Prof Soyer also discusses develops in artificial intelligence and what the future holds for this technology.
This podcast provides a sneak peek into Prof Soyer’s upcoming in-depth presentation at the Skin & Skin Cancer Conference and Masterclasses in Brisbane on 21-24 July 2022.

Friday May 20, 2022
Contemporary management of melanoma with Prof Michael Henderson
Friday May 20, 2022
Friday May 20, 2022
In this latest podcast, Professor Michael Henderson (Professor of Surgery at the University of Melbourne) gives a sneak peek into his presentation at the upcoming Skin & Skin Cancer Conference and Masterclasses in Brisbane on 21-24 July 2022, where he will talk about contemporary management of melanoma.
In the podcast, Prof Henderson talks with Professor David Wilkinson (Chief Medical Officer of National Skin Cancer Centres) about the big changes that are happening with melanoma management in primary care and within advanced facilities, too.
Melanoma treatments are rapidly evolving and have come a long way in recent years – and there are a lot of changes coming in the near future!
Prof Henderson speaks about the management of high-risk melanoma patients, the role of the sentinel node biopsy, candidates for adjuvant therapies such as immunotherapy, updates to Australian melanoma treatment guidelines, the management of melanoma by GPs in the primary care setting, and more.

Thursday May 05, 2022
Thursday May 05, 2022
In this latest podcast, Prof David Wilkinson (Chief Medical Officer of National Skin Cancer Centres) speaks with Dr Yevgeny (Gene) Filanovsky (a Family Physician with Cutaneous Surgery and Skin Cancer Focus at Skin Care West, Canada) about his extensive experience using topical 5 fluorouracil-calcipotriol compound to treat actinic keratosis.
Dr Filanovsky describes how he got started in skin cancer medicine and came to work full-time in cutaneous surgery at Skin Care West, which utilises a team-based approach combining dermatologists and family physicians. It is quite unique in Canada and is one of the largest dermatology clinics in its province.
Dr Filanovsky goes on to give a very detailed explanation of his experiences with topical 5 fluorouracil-calcipotriol compound use for actinic keratosis. He has treated over 1,000 patients with this treatment. Download his handout here and his slides here.

Wednesday Apr 20, 2022
Antibiotic prophylaxis for surgical site infection
Wednesday Apr 20, 2022
Wednesday Apr 20, 2022
In this latest podcast, Dr Helena Rosengren – a Skin Cancer & Aesthetic Doctor in Townsville, Queensland – gives a sneak peek into her presentation at the upcoming Skin & Skin Cancer Conference and Masterclasses in Brisbane on 21-24 July 2022, where she will talk about antibiotic prophylaxis for surgical site infection.
In the podcast, Dr Rosengren talks about how she got started in skin cancer medicine after working as a general practitioner for most of her career. She describes the prevalence and management of wound infections following skin procedures.
Dr Rosengren offers her expert advice for GPs on a pragmatic approach to antibiotic prophylaxis for surgical site infection, drawing on recent research that shows Australia has the highest antibiotic prescribing rate in the world. She explains how to manage high-risk sites and high-risk patients.

Wednesday Mar 23, 2022
Managing adverse events & improving safety in aesthetic medicine
Wednesday Mar 23, 2022
Wednesday Mar 23, 2022
In this latest podcast, Elena Currie (Co-founder, Aesthetic MET) discusses the results of a recent aesthetics safety survey exploring adverse events experienced by practitioners performing cosmetic procedures, and highlights how these results can help improve safety standards in medical aesthetics.
Elena explains how the survey provides an insight into complications that are realistically relevant to (and experienced by) peers. For example, the survey found that 26% of practitioners have experienced vascular occlusion – an adverse reaction that attracts a substantial amount of fear, considering it can be treated swiftly when recognised. In reality, only about 4% of vascular occlusions lead to necrosis.
The survey discussion aims to provide a snapshot of what adverse reactions are commonly experienced and how well they are handled, and to lessen practitioners’ uncertainty around adverse events.

Thursday Mar 10, 2022
How doctors’ percentage fees affect their income
Thursday Mar 10, 2022
Thursday Mar 10, 2022
Do doctors’ percentage fees actually matter? In this latest episode of the HealthCert Education podcast, Paul Elmslie (Founder & CEO, HealthCert Education and National Skin Cancer Centres) speaks with Matt Woollard (Business Director, National Skin Cancer Centres) about how doctors’ percentage fee structures affect the income of both doctors and medical practices.
Read the rest of this entry »
Monday Feb 21, 2022
The Practice Manager’s impact on the clinic’s performance
Monday Feb 21, 2022
Monday Feb 21, 2022
In this latest episode of the HealthCert Education podcast, Paul Elmslie (Founder & CEO, HealthCert Education and National Skin Cancer Centres) speaks with Mark Lindley (Head of People & Culture, National Skin Cancer Centres) about the role of a Practice Manager in a medical clinic.
Read the rest of this entry »
Wednesday Jan 12, 2022
Wednesday Jan 12, 2022
Do you educate your patients about the importance of regular skin cancer checks? Catch this latest podcast with Prof David Wilkinson and Dr John Hall on why skin checks are essential for all Australians, and register yourself or your practice for the upcoming Australia’s National Skin Check Day to help save lives!
Read the rest of this entry »
Friday Dec 17, 2021
Friday Dec 17, 2021
Welcome to this podcast series, Conversations with Professor David Wilkinson! In this episode, Prof David Wilkinson (Chief Medical Officer, National Skin Cancer Centres) speaks with Prof Luc Thomas (Professor and Chairman, Department of Dermatology, Medical University of Lyon, France) about how to manage skin cancers of the nail, with a particular focus on their treatment.
Read the rest of this entry »